Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique

This publication has 29 references indexed in Scilit:

• Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
  New England Journal of Medicine, 2013
• First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
  New England Journal of Medicine, 2011
• A Research Agenda for Malaria Eradication: Vaccines
  PLOS Medicine, 2011
• Evaluation of the Persistence of Vaccine-Induced Protection with Human Vaccines
  Journal of Comparative Pathology, 2010
• Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
  The Journal of Infectious Diseases, 2009
• Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
  The Journal of Infectious Diseases, 2009
• GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
  Expert Review of Vaccines, 2007
• Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2001
• Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine
  The Journal of Infectious Diseases, 1998
• A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria
  New England Journal of Medicine, 1997